The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia. PCS programs are designed to stimulate in-depth discussions on common and/or leading bottleneck issues related to crystallization of drug substance (DS) as well as the intermediates, the technologies and solutions that are available or underdevelopment. The discussions help new medicine developers to make educated and phase-appropriate decisions, and crystallization experts to understand better the critical needs for providing effective solutions.

The Pharma Crystallization Summit (PCS) has been serving effectively for bridging the gap between drug substance (DS) and drug product (DP) developments. PCS 2023 will be held on October 5 – 6 at New Jersey Institute of Technology (NJIT), Newark, NJ, USA. Extending from the valued topics in the past, this 4th PCS will focus on the following topics:

Session I: Enabling Greener DS Synthetics Routes

Session II:  Enabling Desired DS Quality Attributes

Session III: Enabling Improved DP Performance

Panel Discussion Topics:

1) Crystallization challenges and dream solutions supporting synthetic route optimization

2) API isolation challenges and better solutions to ensure robust production

3) Addressing formulation challenges via particle engineering and co-processing

End of Summit & See you in 2024!